An Sermon

Prof. An Sermon

KU Leuven - Department of Development and Regeneration

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Injury
Verified
Journal Article
Closed access
Willem‐Jan MetsemakersWillem‐Jan Metsemakers
Willem‐Jan Metsemakers
KHK. Handojo
K. Handojo
PRP. Reynders
P. Reynders
ASAn Sermon
An Sermon
PVP. Vanderschot
P. Vanderschot
Stefaan NijsStefaan Nijs
Stefaan Nijs

1 August 2008 in Injury
Verified
Journal Article
Closed access
ASAn Sermon
An Sermon
PBP. Broos
P. Broos
PVP. Vanderschot
P. Vanderschot

1 August 2018 in Injury
Verified
Journal Article
Open access
CKChristian Kammerlander
Christian Kammerlander
EHEinar S. Hem
Einar S. Hem
TKTim Klopfer
Tim Klopfer
FGFlorian Gebhard
Florian Gebhard
ASAn Sermon
An Sermon
MBMichael Blauth
Michael Blauth
New implant designs like the Proximal Femoral Nail Antirotation (PFNA) were developed to reduce failure rates in unstable pertrochanteric fractures in the elderly. Standardized implant augmentation with up to 6 mL of polymethylmethacrylate (PMMA) cement has been introduced to enhance implant anchorage by increasing the implant-bone interface in osteoporotic bone conditions. Biomechanically, loads to failure were significantly higher with augmentation. The primary objective of this study was to compare the mobility of patients with closed unstable trochanteric fractures treated by PFNA either with or without cement augmentation. A prospective multicentre, randomized, patient-blinded trial was conducted with ambulatory patients aged 75 or older who sustained a closed, unstable trochanteric fracture. Surgical fixation had to be performed within 72 h after admission. Outcomes were evaluated at baseline, during surgery, 3 to 14 days after surgery, 3 months, 6 months, and 12 months after surgery. To evaluate the primary objective, patients' walking speed was assessed by the Timed Up and Go (TUG) test. Secondary objectives included the analysis of implant migration assessed on radiographs, quality of life measured by the Barthel Index, mobility measured by the Parker Mobility Score, and complications. Of 253 randomized patients, 223 patients were eligible: 105 patients were allocated to the PFNA Augmentation group and 118 to PFNA group. At 3 to 14 days after surgery, there was no statistical significant difference in mean walking speed between the treatment groups. For the secondary objectives, also no statistical significant differences were found. However, no patient in the PFNA Augmentation group had a reoperation due to mechanical failure or symptomatic implant migration compared to 6 patients in the PFNA group. Augmentation of the PFNA blade did not improve patients' walking ability compared to the use of a non-augmented PFNA but might have the potential to prevent reoperations by strengthening the osteosynthesis construct.

30 June 2011 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
MDMieke Deschodt
Mieke Deschodt
TBTom Braes
Tom Braes
PBPaul Broos
Paul Broos
ASAn Sermon
An Sermon
SBSteven Boonen
Steven Boonen
KMKoen Milisen
Koen Milisen

21 October 2011 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
SBSteven Boonen
Steven Boonen
EOEric S Orwoll
Eric S Orwoll
JMJay Magaziner
Jay Magaziner
CCCathleen S. Colón‐Emeric
Cathleen S. Colón‐Emeric
JAJonathan D. Adachi
Jonathan D. Adachi
FTFor The Horizon Recurrent Fracture Trial
For The Horizon Recurrent Fracture Trial

1 February 2016 in Injury
Verified
Journal Article
Closed access
ABAlexander Brunner
Alexander Brunner
MBMarkus Büttler
Markus Büttler
ULUwe Lehmann
Uwe Lehmann
HFHans Curd Frei
Hans Curd Frei
RKRenato Kratter
Renato Kratter
RARene Attal
Rene Attal